Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Accium Biosciences Inc
Profile last edited on: 9/28/16      CAGE: 4SVX6      UEI: YTE6FKCGGHN9

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2004
First Award
2008
Latest Award
2008
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

550 17th Avenue Suite 550
Seattle, WA 98122
   (206) 258-8860
   info@acciumbio.com
   www.acciumbio.com
Location: Single
Congr. District: 09
County: King

Public Profile

Accium BioSciences provides accelerator mass spectrometry (AMS) services to the global pharmaceutical and life science industries: pharmacokinetics, metabolism and mass balance. AMS is an ultrasensitive detection platform capable of quantifying 14C-labeled molecules in the 0.001-100 DPM/mL range. Accium launched the first commercial AMS facility in North America in early 2006.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$102,900
Phase II Dollars
$0
Total Awarded
$102,900

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2008 1 NIH $102,900
Project Title: Patient-Specific Therapy Of Glioblastoma Using A Lightly-Labeled [14c]-Temozolomi

Key People / Management

  Glenn Kawasaki -- President, Ceo

  Barbara Alford-Cassel -- Vice President

  Ali Arjomand -- Former President

  Julie Zalikowski -- Director Bioanalytical

Company News

There are no news available.